NL
AGN

NWAM LLC’s Allergan plc AGN Stock Holding History

NWAM LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$882K Sell
4,612
-276
-6% -$49.8K 0.15% 145
2019
Q3 		$823K Buy
4,888
+99
+2% +$16.1K 0.15% 140
2019
Q2 		$802K Sell
4,789
-357
-7% -$49.4K 0.16% 136
2019
Q1 		$753K Buy
5,146
+451
+10% +$65.4K 0.16% 139
2018
Q4 		$628K Sell
4,695
-777
-14% -$127K 0.16% 144
2018
Q3 		$1.04M Buy
5,472
+397
+8% +$72.9K 0.23% 92
2018
Q2 		$846K Sell
5,075
-236
-4% -$37.9K 0.2% 114
2018
Q1 		$894K Buy
5,311
+1,827
+52% +$306K 0.23% 104
2017
Q4 		$570K Sell
3,484
-508
-13% -$91.2K 0.14% 157
2017
Q3 		$818K Buy
3,992
+341
+9% +$79.3K 0.21% 114
2017
Q2 		$888K Sell
3,651
-28
-0.8% -$6.58K 0.15% 103
2017
Q1 		$879K Buy
3,679
+897
+32% +$209K 0.27% 87
2016
Q4 		$584K Sell
2,782
-35
-1% -$7.25K 0.19% 125
2016
Q3 		$863K Buy
2,817
+2,520
+848% +$616K 0.07% 89
2016
Q2 		$248K Sell
297
-571
-66% -$132K 0.1% 196
2016
Q1 		$233K Buy
868
+124
+17% +$35.5K 0.09% 198
2015
Q4 		$233K Buy
+744
New +$222K 0.1% 201

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

NWAM LLC's AGN Position: Q4 2019 in Review

NWAM LLC reduced its Allergan plc (AGN) stake by 5.6% in Q4 2019, selling an estimated $49.8K and leaving 4,612 shares worth $882K. The position accounts for 0.15% of the portfolio, ranked #145.

NWAM LLC first reported a position in AGN in Q4 2015 and has held it in 17 quarters since. The position peaked at $1.04M in Q3 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • NWAM LLC held 4,612 shares of Allergan plc worth $882K as of Q4 2019.
  • NWAM LLC sold 276 Allergan plc shares in Q4 2019, an estimated $49.8K.
  • Allergan plc made up 0.15% of NWAM LLC's portfolio in Q4 2019, its #145 holding.
  • NWAM LLC first reported a position in Allergan plc in Q4 2015 and has held it in 17 quarters since.
  • NWAM LLC's Allergan plc position peaked at $1.04M in Q3 2018.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on NWAM LLC's 13F filing for Q4 2019, filed 23 Jan 2020.